FDA declares end to Wegovy and Ozempic shortage
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
Watch CBS News
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
Weight-loss medications surged in popularity this year. A survey from Kaiser Family Foundation found one in eight adults have taken drugs like Ozempic, Wegovy and Mounjaro. Demand for the drugs has also skyrocketed among younger people. As childhood and adolescent obesity cases skyrocket, the American Academy of Pediatrics now recommends weight loss drugs for some younger patients.
A growing number of young people are receiving prescriptions for GLP-1 weight loss medications like Ozempic and Wegovy. Janet Shamlian examines why.
2024 was a year of historic health headlines. From Ozempic to E. coli, CBS News medical contributor Dr. Céline Gounder joins to look back at the medical stories that defined the year.
The demand for weight loss drugs, like Ozempic and Wegovy, has skyrocketed in the past few years despite the high cost and unpleasant side effects for some people. The New York Times reports some patients are finding a way around both of these concerns by experimenting with microdosing the drugs. Dr. Jeremy Faust, emergency physician at Brigham and Women's Hospital in Boston, joins CBS News to assess the safety and risks of the practice.
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a rule the Biden administration has proposed.
The Biden administration is proposing a new rule that would make popular weight loss drugs like Ozempic covered by Medicare and Medicaid. CBS News medical contributor Dr. Celine Gounder discusses whether the current or next administration can make this happen.
President Biden's proposal to expand Medicaid and Medicare coverage for some weight loss drugs could impact thousands of Americans. CBS News' Alexander Tin breaks down what's known about the expansion.
President Biden's proposal for Medicaid and Medicare coverage for weight loss drugs such as Ozempic and Wegovy could draw opposition from the drug industry and President-elect Donald Trump's administration. Julie Rovner, the chief Washington correspondent for Kaiser Health News, joins CBS News with more.
This may be the first Thanksgiving for millions of Americans who are on GLP-1 agonists like Ozempic, Zepbound or Wegovy.
In 2020, West Virginia started a pilot program providing subsidies for GLP-1 weight loss drugs for state employees. It showed promising results, but the program ended in March, leaving many unable to afford the pricey drugs. Mark Strassmann has the story.
Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide — while adding great heft to the economy of Novo Nordisk’s home country, Denmark.
The demand for weight loss drugs like Ozempic and Wegovy has led to a flood of fake drugs hitting the market. However, these counterfeit medicines can be harmful to people's health. Tom Hanson has more.
Record demand for Ozempic, Wegovy and other weight loss drugs is fueling a surge of dangerous knockoffs.
A surge in counterfeit versions of popular weight loss drugs is raising health concerns. U.S. Customs is intercepting fake medications with potentially harmful effects. Tom Hanson reports on the risks and how consumers can protect themselves.
Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great heft to the economy of Novo Nordisk's home country, Denmark.
Danish company Novo Nordisk has a market cap larger than the entire country's GDP. As it grows, it's having an impact on other industries.
Novo Nordisk scientist Lotte Knudsen, whose research led to Ozempic and Wegovy, started her career developing laundry detergent.
Correspondent Jon Wertheim revisits 60 Minutes' coverage of former mobile giant Nokia and discusses potential risks for the Danish economy.
Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, were looking for a way to tackle diabetes, which the wife suffered from.
A new study shows diabetes drugs like Mounjaro and Ozempic, which people also take to lose weight, may help patients suffering from addiction. CBS News contributor Dr. Celine Gounder explains.
Weight loss drugs are exploding in popularity, with 1 in 8 Americans saying they have tried medications like Ozempic and Wegovy to tackle everything from diabetes to weight loss, among other conditions. As demand rises, many people are turning to copycat alternatives, or compounded versions, of the drugs. CBS News Confirmed looked into the marketplace for these alternatives and found plenty of gray area, with little oversight or protection for consumers.
The Senate Health, Education, Labor and Pension committee, led by Vermont Sen. Bernie Sanders, is hearing testimony from Novo Nordisk CEO Lars Fruergaard Jørgensen on the exhortative prices for their drugs in the U.S. CBS News' Nancy Chen has more.
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the meantime, a market for cheaper, compounded drugs thrives.
Do weight loss drug labels warn enough about potential side effects? A patient who needed emergency surgery is suing prescription drugmaker Novo Nordisk.
Vice President JD Vance told reporters that "we have not reached an agreement" following face-to-face talks with Iranian leaders and Pakistani negotiators.
Gas prices put pressure on pocketbooks — and President Trump's ratings — as Iran war continues.
It is a key moment for populist Prime Minister Viktor Orbán, who has traveled a long road from his early days as a liberal, anti-Soviet firebrand to a Russian-friendly nationalist admired today by the global far-right.
President Trump said the U.S. Navy will begin blockading ships from entering or exiting the Strait of Hormuz and intercept vessels that have paid tolls to Iran.
Pope Leo XIV offered his strongest condemnation yet of the war in Iran on Saturday, appearing to take multiple veiled shots at President Trump.
A horde of 2028 Democratic presidential hopefuls attended Al Sharpton's National Action Network conference, nearly two years before the first primary votes will be cast.
The woman alleged the California gubernatorial candidate sexually assaulted her twice when she was too drunk to consent.
Russian President Vladimir Putin on Thursday declared a 32-hour ceasefire over the Orthodox Easter weekend.
To fuel their artificial intelligence initiatives, tech companies are building massive numbers of AI data centers, with more than 4,000 in operation across the country. But some communities, wary of the environmental and financial implications, are fighting back.
Democratic Sen. Mark Warner said "I'll take a look at anything" when asked whether he would oppose additional funding for the war with Iran.
To fuel their artificial intelligence initiatives, tech companies are building massive numbers of AI data centers, with more than 4,000 in operation across the country. But some communities, wary of the environmental and financial implications, are fighting back.
Seventy-three percent of Americans say delays and denials of medical treatment by healthcare insurers are a major problem. Now, a company called Sheer Health says they will fight insurance battles on behalf of their clients.
President Trump said the U.S. Navy will begin blockading ships from entering or exiting the Strait of Hormuz and intercept vessels that have paid tolls to Iran.
A growing number of young people see themselves as "forever renters" because they can't afford to buy a home, due to short supply, higher mortgage rates, and incomes that haven't kept up with rising home prices.
To fuel their artificial intelligence initiatives, tech companies are building massive numbers of AI data centers, with more than 4,000 in operation across the country. But some communities, wary of the environmental and financial implications, are fighting back.
Seventy-three percent of Americans say delays and denials of medical treatment by healthcare insurers are a major problem. Now, a company called Sheer Health says they will fight insurance battles on behalf of their clients.
China's long-term investments in innovation are paying off in electric vehicles. Last year, the Chinese car company BYD overtook Tesla as the world's top seller of EVs, despite the U.S. market being virtually closed to them.
A growing number of young people see themselves as "forever renters" because they can't afford to buy a home, due to short supply, higher mortgage rates, and incomes that haven't kept up with rising home prices.
The Netherlands' decision now goes to the European Commission for full authorization.
Democratic Sen. Mark Warner said "I'll take a look at anything" when asked whether he would oppose additional funding for the war with Iran.
The following is the transcript of the interview with Israeli Ambassador to the U.S. Michael Leiter that aired on "Face the Nation with Margaret Brennan" on April 12, 2026.
The following is the transcript of the interview with GOP Rep. Mike Turner of Ohio that aired on "Face the Nation with Margaret Brennan" on April 12, 2026.
The following is the transcript of an interview with Democratic Sen. Mark Warner of Virginia that aired on "Face the Nation with Margaret Brennan" on April 12, 2026.
The following is the full transcript of an interview with Kristalina Georgieva, managing director of IMF, that aired on "Face the Nation with Margaret Brennan" on April 12, 2026.
Seventy-three percent of Americans say delays and denials of medical treatment by healthcare insurers are a major problem. Now, a company called Sheer Health says they will fight insurance battles on behalf of their clients.
Jack Alston was used to migraines, but after two concussions in middle school, he was stuck with a headache that wouldn't go away.
Some states already don't have enough staff to quickly process Medicaid applications and answer enrollees' phone calls. Researchers say they may not be prepared to handle new Medicaid work rules, predicting people will lose coverage as a result.
Two more drug-making giants, Abbvie and Genentech, will start selling popular medications on the White House's discounted pharmaceutical site as soon as Monday.
Behind some of the viral physiques lies a troubling trend: the use of a powerful drug never approved for humans.
The following is the transcript of the interview with Israeli Ambassador to the U.S. Michael Leiter that aired on "Face the Nation with Margaret Brennan" on April 12, 2026.
The incident took place at the Citadelle Henri, also known as Citadelle Laferriere, a 19th-century fortress and tourist spot in the northern town of Milot.
The following is the transcript of the interview with GOP Rep. Mike Turner of Ohio that aired on "Face the Nation with Margaret Brennan" on April 12, 2026.
The following is the transcript of an interview with Democratic Sen. Mark Warner of Virginia that aired on "Face the Nation with Margaret Brennan" on April 12, 2026.
The following is the full transcript of an interview with Kristalina Georgieva, managing director of IMF, that aired on "Face the Nation with Margaret Brennan" on April 12, 2026.
Jane Pauley hosts our annual "Money Issue." Featured: Obstacles to home ownership; fighting health insurance denials; Chinese EVs; opposition to AI data centers; American Girl dolls; skin care mogul Scarlett Johansson; roller coasters; the popularity of bingo!; and is your phone eavesdropping on you?
Founded in 1986, American Girl has created dolls, books and accessories that tell the stories of young girls in every American era. On the toy's 40th anniversary, correspondent Faith Salie explores how making history come alive is also creating timeless bonds between generations that celebrate girlhood.
The actress has played many roles in her career – and now, the Tony-winner and two-time Oscar-nominee has taken on another: launching her new line of products, called The Outset, designed for people with sensitive skin (like hers).
In this web exclusive, actress Scarlett Johansson talks about how dealing with her sensitive skin for years led to her founding a new line of skin care products, The Outset. She also discusses her life-changing roles, and the impact of artificial intelligence.
Actress Scarlett Johansson has played many roles in her career – and now, the Tony-winner and two-time Oscar-nominee has taken on another: launching her new line of products, called The Outset, designed for people with sensitive skin (like hers). She talks with correspondent Tracy Smith about her skin struggles, and how husband Colin Jost has been a "guinea pig" for her products.
To fuel their artificial intelligence initiatives, tech companies are building massive numbers of AI data centers, with more than 4,000 in operation across the country. But some communities, wary of the environmental and financial implications, are fighting back.
To fuel their artificial intelligence initiatives, tech companies are building massive numbers of AI data centers, with more than 4,000 in operation across the country. But some communities, wary of the environmental and financial implications of such facilities in their backyards, are fighting back. "Sunday Morning" national correspondent Robert Costa examines the drive to construct AI data centers, and the debate between opponents and AI advocates.
From labor shortages to environmental impacts, farmers are looking to AI to help revolutionize the agriculture industry. One California startup, Farm-ng, is tapping into the power of AI and robotics to perform a wide range of tasks, including seeding, weeding and harvesting.
When ads pop up on your phone for products after you've happened to mention them, is it an indication that advertisers are eavesdropping on you? David Pogue checks out why highly-targeted advertising sometimes gets weirdly specific.
When ads pop up on your phone for products after you've happened to mention them, is it an indication that advertisers are eavesdropping on you? Correspondent David Pogue checks out the facts about highly-targeted advertising, and why it sometimes gets weirdly specific.
Colorado State University has released its annual Atlantic hurricane forecast, predicting 13 named storms and six hurricanes may develop during the 2026 season.
Scientists have found evidence that a 300-million-year-old sea creature previously thought to be the world's oldest octopus is actually a nautilus relative.
Last month was the hottest March on record for the Lower 48 states, by the most for any month ever, federal data shows. And a forecast El Niño could heat Earth even more.
The emperor penguin has been declared an endangered species as climate change pushes the icon of Antarctica a step closer to extinction, the global authority on threatened wildlife says.
The astronauts aboard Artemis II are the first humans to see some parts of the far side of the moon with the naked eye.
Kimberly Langwell, a mom in Beaumont, Texas, had dinner plans with her teenage daughter and boyfriend on July 9, 1999 – but she never came home from work. It would take more than 20 years before one man's long-kept secret would expose her killer.
The drugs were seized at London Gateway, a deep-sea container port about 30 miles from London.
Lynette Hooker was reported missing in the Bahamas one week ago by her husband, Brian, who said she fell off their boat. Hooker was arrested on Thursday in connection to his wife's disappearance. "CBS Saturday Morning" speaks with people who knew the couple to learn more.
A 9-year-old boy was rescued this week after living locked in his father's utility van in eastern France since 2024, according to the local prosecutor.
The U.S. Department of Homeland Security has been drawn into the case of a woman who was killed in a hammer attack last week at a gas station in Fort Myers, Florida, after a Haitian immigrant was taken into custody on homicide charges in connection with the attack. Nicole Valdes has the latest.
The Artemis II astronauts flew back to the Johnson Space Center in Houston Saturday to cheers and applause from family members and hundreds of NASA workers.
The Artemis II crew's nine-day moon mission set a record for the farthest any human has ever traveled from Earth. Here's a look at the key moments.
NASA's Artemis II astronauts returned to Earth with a splashdown landing in the Pacific Ocean after making a high-speed reentry through the atmosphere.
The development of the mission mascot and viral sensation Rise began over a year before Artemis II blasted off.
Despite problems during the unpiloted Artemis I reentry, the Artemis II crew is confident their heat shield will protect them during a fiery descent to Earth.
A look back at the esteemed personalities who've left us this year, who'd touched us with their innovation, creativity and humanity.
Does the evidence show a cover-up, or was Todd Kendhammer wrongfully convicted for the murder of his wife?
Christy Salters-Martin dominated in the boxing ring but faced her toughest challenger at home.
Family seeks answers in death of newlywed who disappeared in 2005 while on Mediterranean honeymoon cruise.
Meet the tattooed beauty charged in the death of Google executive Forrest Hayes.
Missed the second half of the show? Rep. Mike Turner and IMF Managing Director Kristalina Georgieva join. Plus, Anthony Salvanto breaks down the latest CBS News poll.
Jane Pauley hosts our annual "Money Issue." Featured: Obstacles to home ownership; fighting health insurance denials; Chinese EVs; opposition to AI data centers; American Girl dolls; skin care mogul Scarlett Johansson; roller coasters; the popularity of bingo!; and is your phone eavesdropping on you?
Artemis II astronauts Reid Wiseman, Victor Glover, Christina Koch and Jeremy Hansen reflected on their historic moon mission after a successful splashdown on Friday in the Pacific.
Kristalina Georgieva, the managing director of the International Monetary Fund, discusses the impacts of the Iran war on the global economy and other hot-button issues.
GOP Rep. Mike Turner of Ohio defended the president's handling of the Iran war, saying he is focused on preventing Iran from obtaining a nuclear weapon.